Announcements Trials
Browse Landscape

Phase

Phase 2 45Phase 3 22Phase 1/2 8Phase 1 5Phase NA 4Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Skin Diseases 1Neoplasms 1Breast Diseases 1

Interventions

Saline Solution 10Docetaxel 10Bevacizumab 9nilotinib 8enzalutamide 8Paclitaxel 8Letrozole 8Fentanyl 8Everolimus 8Cyclophosphamide 8Carboplatin 8Bupivacaine 8Lidocaine 7Sodium Chloride 6Oxycodone 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Erlotinib Hydrochloride 6Dexamethasone 6Capecitabine 6Trastuzumab 5Tobacco Use Cessation Devices 5Surveys and Questionnaires 5Nivolumab 5Hydromorphone 5Adalimumab 5fludarabine 4Zoledronic Acid 4Tranexamic Acid 4Tacrolimus 4Rocuronium 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Has results × exemestane × Clear all
NCT01176916 2021-10-27

AromasinĀ® Interventional Study Of Early Invasive Breast Cancer Patients In China

Pfizer

Phase 4 Completed
564 enrolled 13 charts
Breast

Breast Neoplasms

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed
52 enrolled 16 charts
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚔